- Report
- August 2025
- 80 Pages
Middle East, Africa
From €3171EUR$3,450USD£2,696GBP
- Report
- August 2025
- 98 Pages
Asia Pacific
From €3631EUR$3,950USD£3,087GBP
- Report
- August 2025
- 101 Pages
Europe
From €3631EUR$3,950USD£3,087GBP
- Report
- August 2025
- 90 Pages
North America
From €3171EUR$3,450USD£2,696GBP
- Report
- June 2025
- 98 Pages
Europe
From €3631EUR$3,950USD£3,087GBP
- Report
- June 2025
- 88 Pages
North America
From €3171EUR$3,450USD£2,696GBP
- Report
- June 2025
- 193 Pages
Global
From €4550EUR$4,950USD£3,869GBP
- Report
- June 2025
- 105 Pages
Global
From €3171EUR$3,450USD£2,696GBP
- Report
- June 2025
- 80 Pages
From €3171EUR$3,450USD£2,696GBP
- Report
- June 2025
- 180 Pages
Global
From €3677EUR$4,000USD£3,126GBP
- Report
- April 2025
- 203 Pages
Global
From €4274EUR$4,650USD£3,634GBP
- Report
- March 2025
- 160 Pages
Global
From €4274EUR$4,650USD£3,634GBP
- Report
- March 2025
- 211 Pages
Global
From €4274EUR$4,650USD£3,634GBP
- Report
- February 2025
- 135 Pages
Global
From €4458EUR$4,850USD£3,790GBP
- Report
- January 2025
- 50 Pages
Global
From €2297EUR$2,499USD£1,953GBP
- Report
- January 2025
- 120 Pages
Global
€4990EUR$5,815USD£4,391GBP
- Report
- December 2024
- 55 Pages
Global
From €2297EUR$2,499USD£1,953GBP
- Report
- October 2024
- 83 Pages
Global
From €4137EUR$4,500USD£3,517GBP
- Report
- October 2024
- 181 Pages
Global
From €4274EUR$4,650USD£3,634GBP
- Report
- September 2024
- 118 Pages
Global
From €4137EUR$4,500USD£3,517GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more